Anti-Protozoan Activities of Polar Fish-Derived Polyalanine Synthetic Peptides

• Published in: Marine drugs Vol. 21; no. 8; p. 434
• Main Authors: Nunes, Ellynes Amancio Correia, da Silva, Maria Cláudia, Cardoso, Marlon Henrique, Preza, Sergio Leandro Espíndola, de Oliveira, Lucas Silva, Frihling, Breno Emanuel Farias, Charneau, Sébastien Olivier, Grellier, Philippe, Franco, Octávio Luiz, Migliolo, Ludovico
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 31-07-2023; MDPI
• Subjects: African trypanosomiasis; Animal products; antimicrobial peptide; antiplasmodial peptide; Chagas disease; Chemical properties; Cytotoxicity; Design; Drug resistance; Drug therapy; Dynamic structural analysis; E coli; Fish; Health aspects; Human diseases; Illnesses; Infections; Infectious diseases; Lysis; Malaria; Membranes; Molecular dynamics; Parasites; Peptides; Pharmaceutical research; Phospholipids; Polyalanine; Protozoa; Simulation; Synthetic peptides; Tropical diseases; trypanocidal peptide; Vector-borne diseases; Brazil
• ISSN: 1660-3397; 1660-3397
• DOI: 10.3390/md21080434

Chagas disease, sleeping sickness and malaria are infectious diseases caused by protozoan parasites that kill millions of people worldwide. Here, we performed in vitro assays of Pa-MAP, Pa-MAP1.9, and Pa-MAP2 synthetic polyalanine peptides derived from the polar fish Pleuronectes americanus toward Trypanosoma cruzi, T. brucei gambiense and Plasmodium falciparum activities. We demonstrated that the peptides Pa-MAP1.9 and Pa-MAP2 were effective to inhibit T. brucei growth. In addition, structural analyses using molecular dynamics (MD) studies showed that Pa-MAP2 penetrates deeper into the membrane and interacts more with phospholipids than Pa-MAP1.9, corroborating the previous in vitro results showing that Pa-MAP1.9 acts within the cell, while Pa-MAP2 acts via membrane lysis. In conclusion, polyalanine Pa-MAP1.9 and Pa-MAP2 presented activity against bloodstream forms of T. b. gambiense, thus encouraging further studies on the application of these peptides as a treatment for sleeping sickness.